Arrested alveolar development in bronchopulmonary dysplasia

Lung Development and Regeneration

Volumn , Issue , 2004, Pages 1-19

  Coalson, Jacqueline J ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745935618     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (67)

1. Northway W, Rosan R, Porter D. Pulmonary disease following respirator therapy of hyaline membrane disease: bronchopulmonary dysplasia. N Engl J Med 1967; 276:357-368.
2. Chambers H, Van Velzen D. Ventilator-associated pathology in the extremely immature lung. Pathology 1989; 21:79-83.
3. Nakamura Y, Hosokawa Y, Nakashima T, Komatsu Y, Nakashima H, Kuyama M, Fukuda S, Hashimoto T. Pulmonary complications of long-term respiratory care in infants. Relationship to bronchopulmonary dysplasia. Acta Pathol Jpn 1981; 31:75-84.
4. Van Lierde S, Cornelis A, Devlieger H, Moerman P, Lauweryns J, Eggermont E. Different patterns of pulmonary sequelae after hyaline membrane disease: heterogeneity of bronchopulmonary dysplasia. Biol Neonate 1991; 60:152-162.
5. Husain A, Siddiqui N, Stocker J. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998; 29:710-717.
6. Stevenson D, Wright L, Lemons J, Oh W, Korones S, Papile L, Bauer CR, Tyson JE, Shankaran S, Fanaroff AA, Donovan EF, Ehrenkranz RA, Verter J. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol 1998; 179:1632-1639.
7. Coalson J. Pathology of chronic lung disease of early infancy. In: Bland, Coalson JJ, eds. Chronic Lung Disease of Early Infancy. NewYork: Marcel Dekker, 2000:85-124.
8. Bonikos D, Bensch K, Northway W, Edwards D. Bronchopulmonary dysplasia: the pulmonary pathologic sequel of necrotizing bronchiolitis and pulmonary fibrosis. Hum Pathol 1976; 7:643-666.
9. Becker M, Koppe J. Pulmonary structural changes in neonatal hyaline membrane disease treated with high pressure artificial respiration. Thorax 1969; 24: 689-694.
10. Pusey V, MacPherson R, Chernick V. Pulmonary fibroplasia following prolonged artificial ventilation of newborn infants. Can Med Assoc J 1969; 100:451-457.
11. Anderson W, Strickland M. Pulmonary complications of oxygen therapy in the neonate. Postmortem study of bronchopulmonary dysplasia with emphasis on fibroproliferative obliterative bronchitis and bronchiolitis. Arch Pathol 1971; 91:506-514.
12. Banerjee C, Girling D, Wigglesworth J. Pulmonary fibroplasia in newborn babies treated with oxygen and artificial ventilation. Arch Dis Child 1972; 47: 509-518.
13. Anderson W, Strickland M, Tsai S, Haglin J. Light microscopic and ultrastructural study of the adverse effects of oxygen therapy on the neonate lung. Am J Pathol 1973; 73:327-348.
14. Rosan CR. Hyaline membrane disease and a related spectrum of neonatal pneumopathies. In: Rosenberg HS, Bolande RP, eds. Perspectives in Pediatric Pathology. Chicago: Year Book Medical Publishers, 1975:15-60.
15. Taghizadeh A, Reynolds E. Pathogenesis of bronchopulmonary dysplasia following hyaline membrane disease. Am J Pathol 1976; 82:241-264.
16. Anderson W, Engel R. Cardiopulmonary sequelae of reparative stages of bronchopulmonary dysplasia. Arch Pathol Lab Med 1983; 107:603-608.
17. Erickson A, de la Monte S, Moore G, Hutchins G. The progression of morphologic changes in bronchopulmonary dysplasia. Am J Pathol 1987; 127:474-487.
18. Sobonya RE, Logvinoff MM, Taussig LM, Theriault A. Morphometric analysis of the lung in prolonged bronchopulmonary dysplasia. Pediatr Res 1982; 16:969-972.
19. Hislop A, Wigglesworth J, Desai R, Aber V. The effects of preterm delivery and mechanical ventilation on human lung growth. Early Hum Dev 1987; 15:147-164.
20. Margraf L, Tomashefski J, Bruce M, Dahms B. Morphometric analysis of the lung in bronchopulmonary dysplasia. Am Rev Respir Dis 1991; 143:391-400.
21. Stocker J. Pathologic features of long-standing “healed” bronchopulmonary dysplasia: a study of twenty-eight 3- to 40-month-old infants. Hum Pathol 1986; 17:943-961.
22. Arroe M, Pedersen-Bjergaard L, Albertsen P, Bode S, Greisen G, Jonsbo F, et al. Inhalation of aerosolized surfactant (Exosurf) to neonates treated with nasal continuous airway pressure. Prenatal Neonatal Med 1998; 3:346-352.
23. Fok T, Al-Essa M, Dolovich M, Rasid F, Kirpalani H. Nebulisation of surfactants in an animal model of neonatal respiratory distress. Arch Dis Child Fetal Neonatal Ed 1998; 78:F3-F9.
24. Bergren E, Liljedahl M, Winbladh G, Andreasson B, Curstedt T, Robertson B, Schollin J. Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome. Acta Paediatr 2000; 89:460-464.
25. Cherukupalli K, Larson J, Rotschild A, Thurlbeck W. Biochemical, clinical, and morphologic studies on lungs of infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1996; 22:215-229.
26. Roberts R, Weesner K, Bucher J. Oxygen-induced alterations in lung vascular development in the newborn rat. Pediatr Res 1983; 21:14-20.
27. Wilson W, Mulle M, Olley P, Rabinovitch M. Hyperoxia-induced pulmonary vascular and lung abnormalities in young rats and potential for recovery. Pediatr Res 1985; 19:1059-1067.
28. Tschanz S, Damke B, Burri P. Influence of postnatally administered glucocorticoids on rat lung growth. Biol Neonate 1995; 68:229-245.
29. Emery J, Mithal A. The number of alveoli in the terminal respiratory unit of man during late intrauterine growth and childhood. Arch Dis Child 1960; 35: 544-547.
30. Loosli C, Potter E. Pre- and postnatal development of the respiratory portion of the human lung. Am Rev Respir Dis 1959; 80(suppl):5-23.
31. Emery J, Wilcock P. The postnatal development of the lung. Acta Anat (Basel) 1966; 65:10-29.
32. Langston C, Kida K, Reed M, Thurlbeck W. Human lung growth in late gestation and in the neonate. Am Rev Respir Dis 1984; 129:607-613.
33. Hislop A, Wigglesworth J, Desai R. Alveolar development in the human fetus and infant. Early Hum Dev 1986; 13:1-11.
34. Broman I. Zur kenntnis der lungenentwicklung. Anat Anz Eng 1923; 57:83-96.
35. Boyden E. Notes on the development of the lung in infancy and early childhood. Am J Anat 1967; 121:749-761.
36. Boyden E. The pattern of the terminal air spaces in a premature infant of 30-32 weeks that lived nineteen and a quarter hours. Am J Anat 1969; 126:31-40.
37. Boyden E. The structure of the pulmonary acinus in a child of six years and eight months. Am J Anat 1971; 132:275-299.
38. Boyden E. Development of the pulmonary airways. Minn Med 1971; 54:894-897.
39. Langston C, Thurlbeck W. Lung growth and development in late gestation and early postnatal life. Perspect Pediatr Pathol 1982; 7:203-235.
40. Zeltner T, Burri P. The postnatal development and growth of the human lung. II. Morphology. Respir Physiol 1987; 67:269-282.
41. Massaro D, Teich N, Maxwell S, Massaro G, Whitney P. Postnatal development of alveoli: regulation and evidence for a critical period in rats. J Clin Invest 1985; 76:1297-1305.
42. Burri P. Structural aspects of prenatal and postnatal development and growth of the lung. In: McDonald JA, ed. Lung Growth and Development. New York: Marcel Dekker, 1997:1-35.
43. Dunnill MS. Postnatal growth of the lung. Thorax 1962; 17:329-333.
44. Thurlbeck W, Angus G. Growth and aging of the normal human lung. Chest 1975; 67(suppl):3S-7S.
45. Bryan MH, Hardie MJ, Reilly BJ, Swyer PR. Pulmonary function studies during the first year of life in infants recovering from the respiratory distress syndrome. Pediatrics 1973; 52:169-178.
46. Edwards D, Dyer W, Northway W. Twelve years’ experience with bronchopulmonary dysplasia. Pediatrics 1977; 59:839-846.
47. Coates A, Bergsteinsson H, Desmond K, Outerbridge E, Beaudry P. Long-term pulmonary sequelae of premature birth with and without idiopathic respiratory distress syndrome. J Pediatr 1977; 90:611-616.
48. Stocks J, Godfrey S, Reynolds EOR. Airway resistance in infants after various treatments for hyaline membrane disease: special emphasis on prolonged high levels of inspired oxygen. Pediatrics 1978; 61:178-183.
49. Kamper J. Long term prognosis of infants with severe idiopathic respiratory distress syndrome. II. Cardio-pulmonary outcome. Acta Paediatr Scand 1978; 67:71-76.
50. Groothius J, Gutierrez K, Lauer B. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics 1988; 82:199-203.
51. Greenough A, Giffin F, Yuksel B. Respiratory morbidity in preschool children born prematurely. Relationship to adverse neonatal events. Acta Paediatr 1996; 85:772-777.
52. Parat S, Moriette M-F, Delaperche P, Escourrou P, Denjean A, Gaultier C. Long-term pulmonary outcome of bronchopulmonary dysplasia and premature birth. Pediatr Pulmonol 1995; 20:289-296.
53. Pelkonen A, Hakulinen A, Turpeinen M. Bronchial lability and responsiveness in school children born very preterm. Am J Respir Crit Care Med 1997; 156:1178-1184.
54. Baralde E, Filippone M, Trevisanuto D, Zanardo V, Zacchello F. Pulmonary function until two years of life in infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med 1997; 155:149-155.
55. Jacob S, Coates A, Lands L, MacNeish C, Riley S, Hornby L, Outerbridge EW, Davis GM. Long-term pulmonary sequelae of severe bronchopulmonary dysplasia. J Pediatr 1998; 133:193-200.
56. Hakulinen A, Jarvenpaa A-L, Turpeinen M, Sovijarvi A. Diffusing capacity of the lung in school-aged children born very preterm, with and without bronchopulmonary dysplasia. Pediatr Pulmonol 1996; 21:353-360.
57. Mitchell S, Teague W. With technical assistance of Amy Robinson. Reduced gas transfer at rest and during exercise in school-age survivors of bronchopulmonary dysplasia. Am J Respir Crit Care Med 1998; 157:1406-1412.
58. Chye J, Gray P. Rehospitalization and growth of infants with bronchopulmonary dysplasia: a matched control study. J Paediatr Child Health 1995; 31:105-111.
59. Hjalmarson O, Sandburg K. Abnormal lung function in healthy preterm infants. Am J Respir Crit Care Med 2002; 165:83-87.
60. Barton L, Hodgman J, Pavlova Z. Causes of death in the extremely low birth weight infant. Pediatrics 1999; 103:446-451.
61. Stahlman M. The goal: prevention of BPD. In: Bland RB, Coalson JJ, eds. Chronic Lung Disease of Early Infancy. New York: Marcel Dekker, 2000:367-376.
62. Bancalari E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am J Perinatology 2001; 18:1-9.
63. Gonzalez A, Sosenko I, Chandar J, Hummler H, Claure N, Bancalari E. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 1996; 128:470-478.
64. Coalson J, Winter V, Siler-Khodr T, Yoder B. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999; 160:1333-1346.
65. Yoder B, Siler-Khodr T, Winter V, Coalson J. High-frequency oscillatory ventilation: effects on lung function, mechanics, and airway cytokines in the immature baboon model of neonatal CLD. Am J Respir Crit Care Med 2000; 162:1867-1876.
66. Coalson J, Thomson M, Yoder B, Winter V, Catland D, Martin H. Early nCPAP ventilation improves lung morphology and decreases lung infection in the baboon model of BPD. Am J Respir Crit Care Med 2002; 165:B39.
67. Roman J. Cell-cell and cell-matrix interactions in development of the lung vasculature. In: McDonald JA, ed. Lung Growth and Development. New York: Marcel Dekker, 1997:355-389.